Vivek K Arora

6PUBLICATIONS
72CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsGenomics and transcriptomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 11, 2025
Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Surendra Nayak, John D Norris, Massimo Ammirante

|Mar 23, 2023
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer.

Kelsy C Cotto, Yang-Yang Feng, Avinash Ramu

|Jan 13, 2023
KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer.

Hong Qiu, Vladimir Makarov, Jennifer K Bolzenius

|Aug 31, 2021
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.

Pradeep S Chauhan, Kevin Chen, Ramandeep K Babbra

|Nov 17, 2017
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.

Angela M Halstead, Chiraag D Kapadia, Jennifer Bolzenius

|Sep 12, 2017
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer.

Neel Shah, Ping Wang, John Wongvipat

Pageof 1

Frequent Collaborators

1 joint publications

Hong Qiu

1 joint publications

Vladimir Makarov

1 joint publications

Jennifer K Bolzenius

1 joint publications

Angela Halstead